JAPAN – Takeda has received the first FDA approval for a treatment for refractory cytomegalovirus (CMV) infections in organ transplant patients, which can lead to complications and even death. Livtencity…
Read MoreTakeda’s drug bags FDA approval for post-transplant Cytomegalovirus infections
